Mice deficient in Muc4 are resistant to experimental colitis and colitis-associated colorectal cancer

Oncogene

Volumn 35, Issue 20, 2016, Pages 2645-2654

  Das, S ^a,d   Rachagani, S ^a   Sheinin, Y ^b   Smith, L M ^a   Gurumurthy, C B ^a   Roy, H K ^c   Batra, S K ^a,b  

^a UNIVERSITY OF NEBRASKA AT OMAHA   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AZOXYMETHANE; DEXTRAN SULFATE; INTERLEUKIN 1BETA; KI 67 ANTIGEN; LYSOZYME; LYSOZYME M; MESSENGER RNA; MUCIN 2; MUCIN 3; MUCIN 4; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD3 ANTIGEN; MUC4 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CD3+ T LYMPHOCYTE; CELL INFILTRATION; CELL PROLIFERATION; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; DIARRHEA; EXPERIMENTAL COLITIS; GENE EXPRESSION; HISTIOCYTE; HISTOPATHOLOGY; INFLAMMATORY CELL; MACROPHAGE; MOUSE; NONHUMAN; OCCULT BLOOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SURVIVAL RATE; TUMOR VOLUME; UPREGULATION; WEIGHT REDUCTION; WILD TYPE; ANIMAL; C57BL MOUSE; COLITIS; COLORECTAL TUMOR; COMPLICATION; DEFICIENCY; DISEASE MODEL; GENE INACTIVATION; GENETICS; IMMUNOLOGY; INTESTINE; MALE; METABOLISM; T LYMPHOCYTE;

ANIMALS; CD3 COMPLEX; COLITIS; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; GENE KNOCKOUT TECHNIQUES; HISTIOCYTES; INTESTINES; MALE; MICE; MICE, INBRED C57BL; MUCIN-4; T-LYMPHOCYTES;

EID: 84941671033     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2015.327     Document Type: Article

References (51)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64: 9-29.
2. Sheng YH, Hasnain SZ, Florin TH, McGuckin MA. Mucins in inflammatory bowel diseases and colorectal cancer. J Gastroenterol Hepatol 2012; 27: 28-38.
3. McGuckin MA, Linden SK, Sutton P, Florin TH. Mucin dynamics and enteric pathogens. Nat Rev Microbiol 2011; 9: 265-278.
4. Van Klinken BJ, Tytgat KM, Buller HA, Einerhand AW, Dekker J. Biosynthesis of intestinal mucins: MUC1, MUC2, MUC3 and more. Biochem Soc Trans 1995; 23: 814-818.
5. Zhang J, Yasin M, Carraway CA, Carraway KL. MUC4 expression and localization in gastrointestinal tract and skin of human embryos. Tissue Cell 2006; 38: 271-275.
6. Boltin D, Perets TT, Vilkin A, Niv Y. Mucin function in inflammatory bowel disease: an update. J Clin Gastroenterol 2013; 47: 106-111.
7. Longman RJ, Poulsom R, Corfield AP, Warren BF, Wright NA, Thomas MG. Alterations in the composition of the supramucosal defense barrier in relation to disease severity of ulcerative colitis. J Histochem Cytochem 2006; 54: 1335-1348.
8. Myerscough N, Warren B, Gough M, Corfield A. Expression of mucin genes in ulcerative colitis. Biochem Soc Trans 1995; 23: 536S.
9. Buisine MP, Desreumaux P, Debailleul V, Gambiez L, Geboes K, Ectors N et al. Abnormalities in mucin gene expression in Crohn's disease. Inflamm Bowel Dis 1999; 5: 24-32.
10. Spicer AP, Rowse GJ, Lidner TK, Gendler SJ. Delayed mammary tumor progression in Muc-1 null mice. J Biol Chem 1995; 270: 30093-30101.
11. Velcich A, Yang W, Heyer J, Fragale A, Nicholas C, Viani S et al. Colorectal cancer in mice genetically deficient in the mucin Muc2. Science 2002; 295: 1726-1729.
12. Sheng YH, Lourie R, Linden SK, Jeffery PL, Roche D, Tran TV et al. The MUC13 cellsurface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis. Gut 2011; 60: 1661-1670.
13. McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ et al. MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest 2007; 117: 2313-2324.
14. Petersson J, Schreiber O, Hansson GC, Gendler SJ, Velcich A, Lundberg JO et al. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am J Physiol Gastrointest Liver Physiol 2011; 300: G327-G333.
15. Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006; 131: 117-129.
16. Chaturvedi P, Singh AP, Batra SK. Structure, evolution, biology of the MUC4 mucin. FASEB J 2008; 22: 966-981.
17. Singh AP, Chaturvedi P, Batra SK. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. Cancer Res 2007; 67: 433-436.
18. Chauhan SC, Singh AP, Ruiz F, Johansson SL, Jain M, Smith LM et al. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125). Mod Pathol 2006; 19: 1386-1394.
19. Mukhopadhyay P, Chakraborty S, Ponnusamy MP, Lakshmanan I, Jain M, Batra SK. Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy. Biochim Biophys Acta 2011; 1815: 224-240.
20. Majhi PD, Lakshmanan I, Ponnusamy MP, Jain M, Das S, Kaur S et al. Pathobiological implications of MUC4 in non-small-cell lung cancer. J Thorac Oncol 2013; 8: 398-407.
21. Miyahara N, Shoda J, Ishige K, Kawamoto T, Ueda T, Taki R et al. MUC4 interacts with ErbB2 in human gallbladder carcinoma: potential pathobiological implications. Eur J Cancer 2008; 44: 1048-1056.
22. Tamada S, Shibahara H, Higashi M, Goto M, Batra SK, Imai K et al. MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma. Clin Cancer Res 2006; 12: 4257-4264.
23. Saitou M, Goto M, Horinouchi M, Tamada S, Nagata K, Hamada T et al. MUC4 expression is a novel prognostic factor in patients with invasive ductal carcinoma of the pancreas. J Clin Pathol 2005; 58: 845-852.
24. Shibahara H, Tamada S, Higashi M, Goto M, Batra SK, Hollingsworth MA et al. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 2004; 39: 220-229.
25. Hoebler C, Gaudier E, De Coppet P, Rival M, Cherbut C. MUC genes are differently expressed during onset and maintenance of inflammation in dextran sodium sulfate-treated mice. Dig Dis Sci 2006; 51: 381-389.
26. Biemer-Huttmann AE, Walsh MD, McGuckin MA, Ajioka Y, Watanabe H, Leggett BA et al. Immunohistochemical staining patterns of MUC1, MUC2, MUC4, MUC5AC mucins in hyperplastic polyps, serrated adenomas, traditional adenomas of the colorectum. J Histochem Cytochem 1999; 47: 1039-1048.
27. Biemer-Huttmann AE, Walsh MD, McGuckin MA, Simms LA, Young J, Leggett BA et al. Mucin core protein expression in colorectal cancers with high levels of microsatellite instability indicates a novel pathway of morphogenesis. Clin Cancer Res 2000; 6: 1909-1916.
28. Ogata S, Uehara H, Chen A, Itzkowitz SH. Mucin gene expression in colonic tissues and cell lines. Cancer Res 1992; 52: 5971-5978.
29. Shanmugam C, Jhala NC, Katkoori VR, Wan W, Meleth S, Grizzle WE et al. Prognostic value of mucin 4 expression in colorectal adenocarcinomas. Cancer 2010; 116: 3577-3586.
30. Perse M, Cerar A. Dextran sodium sulphate colitis mouse model: traps and tricks. J Biomed Biotechnol 2012; 2012: 718617.
31. Feagins LA, Souza RF, Spechler SJ. Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol 2009; 6: 297-305.
32. Bienz M, Clevers H. Linking colorectal cancer to Wnt signaling. Cell 2000; 103: 311-320.
33. MacDonald BT, Tamai K, He X. Wnt/beta-catenin signaling: components, mechanisms, diseases. Dev Cell 2009; 17: 9-26.
34. Luu Y, Junker W, Rachagani S, Das S, Batra SK, Heinrikson RL et al. Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitis. Int J Biochem Cell Biol 2010; 42: 996-1006.
35. Resta-Lenert S, Das S, Batra SK, Ho SB. Muc17 protects intestinal epithelial cells from enteroinvasive E. coli infection by promoting epithelial barrier integrity. Am J Physiol Gastrointest Liver Physiol 2011; 300: G1144-G1155.
36. Ho SB, Luu Y, Shekels LL, Batra SK, Kandarian B, Evans DB et al. Activity of recombinant cysteine-rich domain proteins derived from the membrane-bound MUC17/Muc3 family mucins. Biochim Biophys Acta 2010; 1800: 629-638.
37. Dharmani P, Leung P, Chadee K. Tumor necrosis factor-alpha and Muc2 mucin play major roles in disease onset and progression in dextran sodium sulphateinduced colitis. PLoS One 2011; 6: e25058.
38. Enss ML, Cornberg M, Wagner S, Gebert A, Henrichs M, Eisenblatter R et al. Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm Res 2000; 49: 162-169.
39. Iwashita J, Sato Y, Sugaya H, Takahashi N, Sasaki H, Abe T. mRNA of MUC2 is stimulated by IL-4, IL-13 or TNF-alpha through a mitogen-activated protein kinase pathway in human colon cancer cells. Immunol Cell Biol 2003; 81: 275-282.
40. Kim YD, Jeon JY, Woo HJ, Lee JC, Chung JH, Song SY et al. Interleukin-1beta induces MUC2 gene expression and mucin secretion via activation of PKC-MEK/ERK, PI3K in human airway epithelial cells. J Korean Med Sci 2002; 17: 765-771.
41. Shekels LL, Ho SB. Characterization of the mouse Muc3 membrane bound intestinal mucin 5' coding and promoter regions: regulation by inflammatory cytokines. Biochim Biophys Acta 2003; 1627: 90-100.
42. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol 2003; 3: 521-533.
43. Singh AP, Moniaux N, Chauhan SC, Meza JL, Batra SK. Inhibition of MUC4 expression suppresses pancreatic tumor cell growth and metastasis. Cancer Res 2004; 64: 622-630.
44. Singh AP, Senapati S, Ponnusamy MP, Jain M, Lele SM, Davis JS et al. Clinical potential of mucins in diagnosis, prognosis, therapy of ovarian cancer. Lancet Oncol 2008; 9: 1076-1085.
45. Singh PK, Hollingsworth MA. Cell surface-associated mucins in signal transduction. Trends Cell Biol 2006; 16: 467-476.
46. Senapati S, Das S, Batra SK. Mucin-interacting proteins: from function to therapeutics. Trends Biochem Sci 2010; 35: 236-245.
47. Senapati S, Chaturvedi P, Sharma P, Venkatraman G, Meza JL, El-Rifai W et al. Deregulation of MUC4 in gastric adenocarcinoma: potential pathobiological implication in poorly differentiated non-signet ring cell type gastric cancer. Br J Cancer 2008; 99: 949-956.
48. Ponnusamy MP, Lakshmanan I, Jain M, Das S, Chakraborty S, Dey P et al. MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells. Oncogene 2010; 29: 5741-5754.
49. Ponnusamy MP, Seshacharyulu P, Vaz A, Dey P, Batra SK. MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells. J Ovarian Res 2011; 4: 72215-47.
50. Lobe CG, Koop KE, Kreppner W, Lomeli H, Gertsenstein M, Nagy A. Z/AP, a double reporter for cre-mediated recombination. Dev Biol 1999; 208: 281-292.
51. Araki A, Kanai T, Ishikura T, Makita S, Uraushihara K, Iiyama R et al. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis. J Gastroenterol 2005; 40: 16-23.